Skip to main content
DEVA HOLDİNG A.Ş. logo

DEVA HOLDİNG A.Ş. — Investor Relations & Filings

Ticker · DEVA ISIN · TRADEVAW91E2 LEI · 959800K5PD9GB1EHW234 IS Manufacturing
Open in API
Filings indexed 1,636 across all filing types
Latest filing 2023-05-05 Regulatory Filings
Country ES Spain
Listing IS DEVA

About DEVA HOLDİNG A.Ş.

https://www.deva.com.tr

Established in 1958, DEVA Holding A.Ş. is a pharmaceutical company focused on the development, production, and marketing of medicinal products for human use and active pharmaceutical ingredients (APIs). The company also produces veterinary drugs. DEVA Holding maintains a diverse product portfolio, which includes antineoplastic and immunomodulating agents, and makes its products available on a global scale. Its international business operations are managed through various models, including distributorships, out-licensing, and direct supply agreements.

Recent filings

Filing Released Lang Actions
Financial Report
Regulatory Filings
2023-05-05 Turkish
Financial Report
Interim / Quarterly Report Classification · 1% confidence The document contains structured financial data, specifically a 'Statement of Financial Position' (Balance Sheet) with line items, XBRL tags, and comparative periods (31.03.2023 and 31.12.2022). This is a comprehensive financial statement typical of an interim or quarterly report, not an announcement or a summary. Given the specific date (Q1 2023), it is classified as an Interim/Quarterly Report. Q1 2023
2023-05-05 English
Approval of the Amendment to the Articles of Association at the General Assembly
Regulatory Filings
2023-04-28 Turkish
Approval of the Amendment to the Articles of Association at the General Assembly
Regulatory Filings Classification · 1% confidence The document explicitly discusses the 'Approval of the Amendment to the Articles of Association at the General Assembly' and details the process, including Capital Market Board (CMB) approval dates and the date of the General Assembly (28.04.2023). This relates to changes in the company's foundational rules and capital structure, which are often discussed at shareholder meetings. However, the core subject is the amendment of the Articles of Association, which falls under Governance Information (CGR) or potentially Capital/Financing Update (CAP) due to the mention of 'Authorized Capital'. Given the focus on amending the Articles of Association, which dictates internal rules and structure, CGR is a strong candidate. Since the document is a 'Material Disclosure Announcement' detailing the approval of a change to the foundational document (Articles of Association), and it is very short (1360 chars), it is an announcement about a corporate governance/capital change event rather than the full report itself. The content strongly aligns with changes in corporate structure/governance rules. Comparing CGR (Governance Information) and CAP (Capital/Financing Update), the amendment of the Articles of Association is fundamentally a governance matter, even if it touches capital. I will classify it as Governance Information (CGR) as it details changes to the company's foundational rules.
2023-04-28 English
Approval of the 2022 Profit Distribution Proposal at the General Assembly.
Regulatory Filings
2023-04-28 Turkish
Approval of the 2022 Profit Distribution Proposal at the General Assembly.
Regulatory Filings
2023-04-28 Turkish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.